¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"radioactive antibody test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • divalent antibody
    À̰¡Ç×ü
  • enzyme labeled antibody
    È¿¼ÒÇ¥ÁöÇ×ü
  • enzyme-antibody conjugate
    È¿¼ÒÇ×üÁ¢ÇÕü
  • fluorescent antibody
    Çü±¤Ç×ü
  • fluorescent antibody technique
    Çü±¤Ç×ü¹ý
  • heat labile antibody
    ¿­¹Î°¨Ç×ü, ¿­ºÒ¾ÈÁ¤Ç×ü
  • hemagglutination inhibition antibody
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦Ç×ü
  • hemolytic antibody
    ¿ëÇ÷Ç×ü
  • heterocytotropic antibody
    ÀÌÁ¾¼¼Æ÷ģȭÇ×ü
  • heterophil antibody
    ÀÌÁ¾Ä£È­Ç×ü
  • heterophil antibody reaction
    ÀÌÁ¾Ä£È­Ç×ü¹ÝÀÀ
  • homologous antibody
    µ¿Á¾Ç×ü
  • humoral antibody
    ü¾×Ç×ü
  • hybrid antibody
    ÀâÁ¾Ç×ü
  • isogenic antibody
    µ¿Á¾Ç×ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • heat labile antibody
    ¿­¹Î°¨Ç×ü
  • hemagglutination inhibition antibody
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦Ç×ü
  • hemolytic antibody
    ¿ëÇ÷Ç×ü
  • heterocytotropic antibody
    ÀÌÁ¾¼¼Æ÷ģȭÇ×ü
  • heterogenetic antibody
    (¢¡heterophil antibody) ÀÌÁ¾Ä£È­Ç×ü
  • heterophil antibody
    ÀÌÁ¾Ä£È­Ç×ü
  • homocytotropic antibody
    (¢¡cytotropic antibody) ¼¼Æ÷ģȭÇ×ü
  • homologous antibody
    »óµ¿Ç×ü
  • humoral antibody
    ü¾×Ç×ü
  • hybrid antibody
    ÀâÁ¾Ç×ü
  • immobilizing antibody
    ¿îµ¿¾ïÁ¦Ç×ü
  • immunofluorescence antibody
    ¸é¿ªÇü±¤Ç×ü
  • incomplete antibody
    ºÒ¿ÏÀüÇ×ü
  • inhibiting antibody
    ¾ïÁ¦Ç×ü
  • isogenic antibody
    µ¿Á¾Ç×ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • antibody production
    Ç×ü»ý»ê(¡­ßæß§).
  • antibody removal
    Ç×üÁ¦°Å
  • antibody response
    Ç×ü¹ÝÀÀ(¡­Úãëë).
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody structure
    Ç×ü±¸Á¶(¡­Ï°ðã).
  • antibody synthesis =a. production
    Ç×ü»ý»ê, Ç×üÇÕ¼º.
  • antibody titer
    Ç×ü°¡(ù÷ô÷ʤ).
  • antibody to HBc ag
    B Çü °£¿°ÇÙ½ÉÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HBe ag
    B Çü °£¿°¿ÜÇÇÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HBs ag
    B Çü °£¿°Ç¥¸éÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HD ag
    HD Ç׿ø¿¡´ëÇÑ Ç×ü
  • antibody to histidyl tRNa synthetase
    È÷½ºÆ¼µô tRNa ÇÕ¼ºÈ¿¼Ò¿¡ ´ëÇÑ Ç×ü
  • antibody to thyroglobulin
    Ƽ·Î±Û·ÎºÒ¸°<°©»ó¼±±Û·ÎºÒ¸°>¿¡ ´ëÇÑ Ç×ü
  • antibody to thyrotropin
    °©»ó¼±ÀÚ±ØÈ£¸£¸ó¿¡ ´ëÇÑ Ç×ü
  • antibody transfer
    Ç×üÀÌÀÔ(¡­ì¹ìý).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀ̱â±âÀü.
  • antibody formation
    Ç×üÇü¼º(ù÷ô÷û¡à÷).
  • antibody forming cell
    Ç×ü»ý»ê¼¼Æ÷(ù÷ô÷ßæß§á¬øà).
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • antibody producing cell
    Ç×ü»ý»ê¼¼Æ÷
  • antibody production
    Ç×ü»ý»ê(¡­ßæß§).
  • antibody removal
    Ç×üÁ¦°Å
  • antibody response
    Ç×ü¹ÝÀÀ(¡­Úãëë).
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody structure
    Ç×ü±¸Á¶(¡­Ï°ðã).
  • antibody synthesis =a. production
    Ç×ü»ý»ê, Ç×üÇÕ¼º.
  • antibody titer
    Ç×ü°¡(ù÷ô÷ʤ).
  • antibody to HBc ag
    B Çü °£¿°ÇÙ½ÉÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HBe ag
    B Çü °£¿°¿ÜÇÇÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HBs ag
    B Çü °£¿°Ç¥¸éÇ׿ø¿¡´ëÇÑ Ç×ü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • complement fixation inhibition test
    º¸Ã¼°íÁ¤ ÀúÇØ½ÃÇè(ÜÍô÷ͳïÒîÁúªãËúÐ)
  • complement fixation test
    º¸Ã¼°íÁ¤½ÃÇè(ÜÍô÷ͳïÒãËúÐ)
  • consumption test
    ¼Ò¸ð½ÃÇè(á¼ÙÄãËúÐ)
  • Coombs' test
    ÄñÁî ½ÃÇè(ãËúÐ)
  • cross-agglutination test
    ±³Â÷ÀÀÁý °Ë»ç(Îßó©ëêó¢ËþÞÛ)
  • Farr test
    ÆÄ¾Æ ½ÃÇè (ãËúÐ)
  • Fehling's test
    Æç¸µ ½ÃÇè(ãËúÐ)
  • fluctuation test
    ¿äµ¿ ½ÃÇè(èôÔÑãËúÐ)
  • Fouchet's test
    Ǫ½¦ °Ë»ç(ËþÞÛ)
  • F test
    F ½ÃÇè(ãËúÐ)
  • galactose tolerance test
    °¶¶ôÅ佺 ³»¼º°Ë»ç(Ò±àõËþÞÛ)
  • glucose tolerance test
    ±Û·çÄÚ½º ³»¼º °Ë»ç(Ò±àõì×í­)
  • hapten inhibition test
    ÇÕÅÙ ÀúÇØ½ÃÇè(ãËúÐ)
  • Harris-Ray test
    ÇØ¸®½º-·¡ÀÌ ½ÃÇè(ãËúÐ)
  • Heller's test
    Çï·¯ ½ÃÇè(ãËúÐ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
FAST flow-assisted, short-term [balloon catheter]; fluorescent antibody staining technique; fluoro-allerg...
HI antibody Hemagglutination Inhibiting antibody; Ç÷±¸ ÀÀÁý ¾ïÁ¦ Ç×ü
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
AIA allylisopropylacetamide; amylase inhibitor activity; anti-immunoglobulin antibody; anti-insulin anti...
ANA acetylneuraminic acid; American Narcolepsy Association; American Neurological Association; American ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
ASC Antibody secreting cells
anti-HAV Antibody to HAV
anti-HBs Antibody to HBsAg
anti-HCV Antibody to HCV
anti-HDV Antibody to HDV
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adsorption test
    ÈíÂø ½ÃÇè
  • agglutination test
    ÀÀÁý ½ÃÇè
  • agglutinin absorption test
    ÀÀÁý¼Ò Èí¼ö ½ÃÇè
    ¸é¿ª Ç÷û Áß¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Â ºÒÇÊ¿äÇÑ ÀÀÁý¼Ò¸¦ Á¦¿ÜÇϰí, ƯÁ¤ÇÑ ÀÀÁý¼Ò¸¸À» ÇÔÀ¯ÇÏ´Â ÀÎÀÚ Ç÷ûÀ» ¸¸µå´Â ¹æ¹ý. ¸é¿ª Ç÷û¿¡ ÇÊ¿äÇÑ ÀÀÁý¼Ò¿¡ ´ëÇÑ ÀÀÁý¿ø
  • air test
    °ø±â ½ÃÇè
  • alkali denaturation test
    ¾ËÄ®¸® º¯¼º ½ÃÇè
    žƼº Çì¸ð±Û·ÎºóÀÇ ³óµµ¸¦ ÃøÁ¤ÇÏ´Â ºÐ±¤ºñ»ö¹ýÀ¸·Î, °¨µµ´Â ÁßÁ¤µµÀÌ´Ù. ÀÌ ½ÃÇèÀº Çì¸ð±Û·Îºó ºÐÀÚ°¡ ¾ËÄ®¸®¿¡ ³ëÃâµÇ¾úÀ» ¶§ ±Û·Îºó ºÎºÐÀÇ º¯¼º¿¡ ´ëÇÑ Çì¸ð±Û·Îºó ºÐÀÚÀÇ ÀúÇ×µµ¿¡ ´Þ·Á ÀÖ´Ù.
  • Allen's test
    ¾Ë·» ½ÃÇè
  • allergen test
    ¾Ë·¹¸£°Õ ½ÃÇè
    ¾Ë·¹¸£±â¼º ÁúȯÀÇ ¿øÀÎÀÌ µÇ´Â ¾Ë·¹¸£°ÕÀ» °ËÃâ, È®ÀÎÇÏ´Â °Ë»ç¹ý. ½ÃÇè°ü³» ¹ÝÀÀ°ú »ýü ³» ¹ÝÀÀÀ¸·Î ³ª´¶´Ù. ½ÃÇè°ü³» ¹ÝÀÀ¿¡´Â Ç÷ûÇÐÀû ¹ÝÀÀ ¿Ü¿¡ ¹éÇ÷±¸ ¿ëü¹ÝÀÀÀ̳ª Ç÷¼ÒÆÇ ¿ëÇØ¹ÝÀÀ, È÷½ºÅ¸¹Î À¯¸®½ÃÇè, Å»°ú¸³ ½ÃÇè µîÀÌ ÀÖ´Ù. »ýü³» ¹ÝÀÀÀº, Á÷Á¢ ȯÀÚ¿¡°Ô ¾Ë·¹¸£°ÕÀ» Åõ¿©ÇÏ¿©, Áõ¼¼ÀÇ ¹ßÇöÀ» Á¶»çÇÏ´Â À¯¹ß½ÃÇè°ú, ´Ù¸¥ °Ç°­ÇÑ »ç¶÷¿¡°Ô ȯÀÚÀÇ Ç÷û, ¶Ç´Â ¹éÇ÷±¸¸¦ ÁÖ»çÇÑ ÈÄ ¾Ë·¹¸£°ÕÀ» Åõ¿©ÇÏ¿© ¹ÝÀÀÀ» º¸´Â Çǵ¿¼º Àü°¡½ÃÇèÀ¸·Î ³ª´¶´Ù. ÀüÀÚ¿¡´Â ÇǺΠ¹ÝÀÀÀ̳ª Á¡¸· ¹ÝÀÀÀÌ ÀÖ°í, ÈÄÀÚ¿¡´Â ÇÁ¶ó¿ì½º´ÏÃ÷-Äû½ºÆ®³Ê ¹ÝÀÀÀÌ ÀÖ´Ù.
  • alternate binaural loudness balance test
    ±³´ë¼º À½ Å©±â ÆòÇü ½ÃÇè, ¾çÀ̱³´ë À½ÆòÇü°Ë»ç, ¾çÀ̱³´ë¼º À½ÆòÇü °Ë»ç
  • alternate prism cover test
    ±³´ë ÇÁ¸®Áò °¡¸² °Ë»ç
  • Ames test
    ¿¡ÀÓ½º ½ÃÇè, ¿¡ÀÓ½º ½ÇÇè, µ¹¿¬º¯ÀÌ À¯¹ß ½ÃÇè
    1. ¿ÜÀμº È÷½ºÆ¼µòÀ» ÇÊ¿ä·Î ÇÏ´Â »ì¸ð³Ú¶ó ƼÇǹ¸®¿òÀÇ µ¹¿¬º¯ÀÌÁ¾À» ÀÌ¿ëÇÏ¿© È÷½ºÆ¼µòÀ» Á¦¿ÜÇÑ ¹èÁö¿¡ ½ÃÇèÇÒ È­Çй°ÁúÀ» ¿Ã·Á³õ¾Æ µ¹¿¬º¯ÀÌÁ¾ÀÌ Á¤»óÁ¾À¸·Î º¯È­½Ãų °¡´É¼ºÀÌ Å« °ÍÀ̹ǷΠ±×¸¸Å­ ¹ß¾Ï¼ºÀÌ Å©´Ù°í ÇÒ ¼ö ÀÖ´Ù. 2. ¹ß¾Ï¼º ¹°Áú ÃßÃâÀ» À§ÇÑ ½ÃÇèÀ¸·Î, È÷½ºÆ¼µò ÇÕ¼º¿¡ ÇÊ¿äÇÑ È¿¼Ò¸¦ °á¿©Çϰí ÀÖ´Â Salmonella ty
  • aminopyrine breath test
    ¾Æ¹Ì³ëÇǸ° È£Èí °Ë»ç
  • anesthetic test of pulp
    Ä¡¼ö ¸¶Ãë °Ë»ç
  • antiglobulin test
    Çױ۷κθ° °Ë»ç, Çױ۷κθ° ½ÃÇè
    ºÒ¿ÏÀü Ç×ü°¡ ÀûÇ÷±¸¿Í °áÇÕÇϸ鼭 ºñÀÀÁý¼ºÀÎ °æ¿ì, ŸÁ¾ µ¿¹°¿¡¼­ ÀÛ¼ºÇÑ Ç× IgG Ç×ü¸¦ Ãß°¡ÇÔÀ¸·Î½á ´Ù¸®°¡ ³õ¾ÆÁ® ÀÀÁý¹ÝÀÀÀÌ ¹ß»ýÇÑ´Ù. 1945³â Coombs¿¡ ÀÇÇÏ¿© Àç¹ß°ßµÈ ¹æ¹ýÀÌ¸ç »ýü ³»¿¡¼­ ÀÌ¹Ì ÀûÇ÷±¸¿Í °áÇÕÇϰí ÀÖ´Â Ç×ü¸¦ °ËÃâÇÏ´Â Á÷Á¢ ½ÃÇè°ú À¯¸®ÇØ ÀÖ´Â Ç×ü¸¦ ÀûÇ÷±¸¿Í °áÇÕ½ÃŰ°í ³ª¼­ °ËÃâÇÏ´Â °£Á¢ ½ÃÇèÀÌ ÀÖ´Ù.
  • apomorphine test
    ¾ÆÆ÷¸ð¸£ÇÉ ½ÃÇè
  • Apt test
    ¾ÐÆ® ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
heterophil antibody A heterogenetic antibody specific for the Forssman group of heterogenetic antigens.
Synonym: heterophil antibody, heterophile antibody.
(05 Mar 2000)
heterophile antibody <immunology> An antibody raised against an antigen from one species that also reacts against antigens from other species.
Also used of Forssman type systems where antibody against antigens from a variety of species is present without immunisation.
(18 Nov 1997)
heterospecific antibody <immunology> Artificially produced antibody in which the two antigen binding sites are for different antigens.
(18 Nov 1997)
secondary antibody deficiency Immunodeficiency in which there is no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins such as occurs in familial idiopathic hypercatabolic hypoproteinaemia or in defects associated with the nephrotic syndrome.
Synonym: secondary agammaglobulinaemia, secondary antibody deficiency, secondary hypogammaglobulinaemia.
(05 Mar 2000)
secondary antibody response An antibody made upon second (subsequent) exposure to an antigen, mostly of the class IgG.
(09 Oct 1997)
homocytotropic antibody <immunology> A type of antibody which is able to attach itself to the surfaces of cells without needing specific combining sites. A homocytotropic antibody will only bind to cells which are from the same species as itself.
(09 Oct 1997)
hybrid antibody <immunology> Artificially produced antibody made by fusing hybridomas producing two different antibodies, the hybrid cells produce three different antibodies, only one of which is a heterophilic antibody. Can also be prepared chemically from two antibodies.
(18 Nov 1997)
hyperimmune antibody An antibody which occurs in a hyperimmune individual and which targets the antigen that has brought on the hyperimmunity.
(09 Oct 1997)
natural antibody Antibody demonstrable in the serum or plasma of various persons or animals not known to have been stimulated by specific antigen, either artificially or as the result of naturally occurring contact.
Synonym: natural antibody.
(05 Mar 2000)
neutralizing antibody A form of antibody that reacts with an infectious agent (usually a virus) and destroys or inhibits its infectivity and virulence; may be demonstrated by means of mixing serum with the suspension of infectious agent, and then injecting the mixture into animals or cell cultures that are susceptible to the agent in question.
(05 Mar 2000)
nonprecipitable antibody Antibody that, under conditions normally employed in precipitin tests, is refractory to precipitation by specific antibody, demonstrable when antigen is added serially in small amounts; nonprecipitating antibody will precipitate under special conditions such as addition of complement.
Synonym: nonprecipitable antibody.
(05 Mar 2000)
nonprecipitating antibody Antibody that, under conditions normally employed in precipitin tests, is refractory to precipitation by specific antibody, demonstrable when antigen is added serially in small amounts; nonprecipitating antibody will precipitate under special conditions such as addition of complement.
Synonym: nonprecipitable antibody.
(05 Mar 2000)
normal antibody Antibody demonstrable in the serum or plasma of various persons or animals not known to have been stimulated by specific antigen, either artificially or as the result of naturally occurring contact.
Synonym: natural antibody.
(05 Mar 2000)
syndrome, antiphospholipid antibody An immune disorder characterised by the presence of abnormal antibodies in the blood associated with certain medical conditions including abnormal blood clotting, migraine headaches, premature miscarriage, and low blood platelet counts (thrombocytopenia).
(12 Dec 1998)
direct fluorescent antibody The straightforward detection of antigens using fluorescent labelled antigen-specific antibody. Because detection of the antigen in a substrate of patient sample (cellular smear, fluid or patient-inoculated culture medium) is the goal, direct fluorescent antibody is seldom quantitative.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á